Friday | April 22, 2022 | |
---|---|---|
7:00am-7:30am | Continental Breakfast and Registration | |
7:30am-8:15am | Pre-Conference Genetics 101 Basic Concepts | |
7:30am | Primer on Genetic Counseling | Feighanne Hathaway, MS, LCGC |
7:50am | Primer on Genomics | Michael Drazer, MD, PhD |
8:10am | Primer on AI | Frederick Howard, MD |
8:30am | Welcome Address | Olufunmilayo Olopade, MBBS, FASCO |
Advanced concepts in germline genomic testing: Refining Hereditary Risk | Moderator: Allison DePersia, MD Susan Hong, MD | |
8:35am | Making sense of panel testing for inherited hematologic malignancies | Jane Churpek, MD |
8:55am | Polygenic risk score: Should clinicians use it? | Montserrat Garcia-Closas, MD, DrPH |
9:15am | Keynote Address I: State of the Art in Breast Cancer Prevention: Defining healthy women at high risk in the Wisdom Study | Laura Esserman, MD, MBA |
9:45am | Q & A with Speakers | |
10:00am | Break | |
Dawn of a New Era for BRCA Mutation Carriers | Moderators: Nan Chen, MD Iris Romero, MD | |
10:30am | Advances in Immunotherapy for Ovarian Cancer | Kunle Odunsi, MD, PhD |
10:50am | Heterogeneity of Breast Cancer; tailoring treatments to reduce long term toxicities in young women | Rita Nanda, MD |
11:10am | Keynote Address II: State of the Art for BRCA Directed Therapies early stage through metastatic disease | Mark Robson, MD |
11:40am | Toward a primary prevention of Breast and Ovarian Cancer in BRCA mutation carriers women | Kathryn Mills, MD |
12:00pm | Outliving Risk: An age-related assessment of cancer risk and its impact on management | Shari Snow, MD |
12:20pm | Q & A with Speakers | |
12:30pm | Case Presentations | Discussion leaders: Kathleen Blazer, EdD, CGS Madeline Pies, MGCS, LCGC Catherine Marcum, DNP, APN Susan Shehayeb, MS, CGC |
1:30pm | Lunch: Non -CME Activities Cancer IQ Ancillary Event | Gold Room |
2:30pm | Distinguished Lecturer: Treatment of BRCA1-positive breast cancer: an observational study | Steve Narod, MD |
BRCA & Men’s Health | Moderators: Russell Szmulewitz, MD Shari Snow, MD | |
3:15pm | Uptake of Genetic Testing in Prostate Cancer Families | Elias Obeid, MD |
3:35pm | Genetic Evaluation of Prostate Cancer: Considerations for Practice | Veda Giri, MD |
3:55pm | Genetics of Breast Cancer in Men | Susan Neuhausen, PhD |
4:15pm | BRCA2-associated male breast cancer: should there be a different surgical approach? | Nora Jaskowiak, MD |
4:35pm | Q & A with Speakers | |
4:45pm | Break | |
5:00pm | Case Presentations | Discussion leaders: Rachelle Manookian, MS, CGC Christine Drogan, MS, CGC Feighanne Hathaway, MS, LCGC Catherine Marcum, DNP, APN |
6:00pm | Poster Reception sponsored by Natera - International Ballroom Foyer |